Colon Pharmaceutical: Report on the fiduciary management affairs of the public issuance of convertible corporate bonds by Sichuan Colon Pharmaceutical Co., Ltd. (2023)

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.